Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno
11
2
2
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 40/100
9.1%
1 terminated/withdrawn out of 11 trials
83.3%
-3.2% vs industry average
36%
4 trials in Phase 3/4
0%
0 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
HIBA-Institutional Registry of Amyloidosis
Role: collaborator
Use of Machine Learning Techniques for Serial Assessment of Systemic Inflammatory Markers in Breast Cancer Patients
Role: collaborator
Monitoring of Breathing Effort Through Pressure Time Product Measurement Using Airway Occlusion Pressure
Role: collaborator
ARVAC-A New Recombinant Coronavirus Disease 2019 (COVID-19) Vaccine
Role: lead
Endoscopic Scoring System Utilization in Inflammatory Bowel Disease
Role: lead
Convalescent Plasma as Potential Therapy for Severe COVID-19 Pneumonia
Role: lead
Dexamethasone for COVID-19 Related ARDS: a Multicenter, Randomized Clinical Trial
Role: lead
Efficacy and Safety of Saccharomyces Boulardii in the Treatment of Small Intestinal Bacterial Overgrowth
Role: lead
Efficacy of a Nasal Spray Containing Iota-Carrageenan in the Prophylaxis of COVID-19 Disease in Health Personnel Dedicated to Patients Care With COVID-19 Disease
Role: collaborator
Asynchrony During Mechanical Ventilation in Patients With Acute Respiratory Distress Syndrome
Role: lead
Early Precut Versus Pancreatic Stent for Post-ERCP Pancreatitis
Role: lead
All 11 trials loaded